Pro Medicus Ltd
ASX:PME
Pro Medicus Ltd
ASX:PME
Price:
111.41 AUD
-0.21%
Market Closed
Updated:
Apr 30, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
78.7
Current
63.4
Median
2.5
Industry
Higher
than median
Higher
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=78.7
Enterprise Value
/
11.5B
Revenue
146.2m
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.6B AUD | 78.7 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.5B USD | 12 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.9 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 3.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4.2 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7.2B USD | 10.8 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 8.1 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.9B SEK | 25.8 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.2B USD | 1.8 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.7 | |
| US |
|
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 11.3 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
70.8
2-Years Forward
EV/S
56.1
3-Years Forward
EV/S
45.5
You don't have any saved screeners yet
